Synapse - Stephen Nimer

Results (347)

Ig V-H and V-L patient-specific PCR: Assessing clonotypic contamination in stem cell components (SCC) mobilized with melphalan in myeloma

Meeting Abstract

Zhou, P.; Zhang, Y.; Martinez, C.; Kalakonda, N.; Nimer, S. D.; Comenzo, R. L.
Blood (2002)

Fulltext@MSK | Save

Sodium salicylate induces G1 arrest and differentiation and inhibits Cdk2 activity in TF-1 cells without inhibiting NF-kappa B

Meeting Abstract

Sokolic, R.; Klampfer, L.; Jackson, G.; Nimer, S.
Blood (2002)

Fulltext@MSK | Save

Autologous transplantation (ASCT) with total body irradiation (TBI) based conditioning appears superior to chemotherapy only (Non-TBI) conditioning for patients with relapsed or primary refractory chemosensitive (CS) diffuse large B-cell lymphoma (DLBCL) who have no extranodal sits (ENS) of disease (dz)

Meeting Abstract

Kewalramani, T.; Moskowitz, C. H.; Zelenetz, A. D.; Malhotra, S.; Qin, J.; Yahalom, J.; Nimer, S. D.
Blood (2002)

Fulltext@MSK | Save

Results of autologous stem cell transplantation (SCT) following stem cell mobilization with melphalan in myeloma patients

Meeting Abstract

Comenzo, R. L.; Costello, S.; Reich, L.; Drake, L.; Zhou, P.; Martinez, C.; Klimek, V.; Kewalramani, T.; Osman, K.; Dhodapkar, M.; more...
Blood (2002)

Fulltext@MSK | Save

A "first in man" study of the safety and PK/PD of an oral FLT3 inhibitor (MLN518) in patients with AML or high risk myelodysplasia

Meeting Abstract

Heinrich, M. C.; Druker, B. J.; Curtin, P. T.; Paquette, R.; Sawyers, C. L.; De Angelo, D. J.; Gilliland, G. D.; Stone, R. M.; Caliguiri, M. A.; Byrd, J. C.; more...
Blood (2002)

Fulltext@MSK | Save

TGF beta induced growth arrest of human hematopoietic cells requires p57KIP2 upregulation

Meeting Abstract

Scandura, J. M.; Boccuni, P.; Nimer, S. D.
Blood (2002)

Fulltext@MSK | Save

Expression and structural integrity of the H-l(3)mbt polycomb group gene in myeloid malignancies and myeloproliferative diseases associated with 20q

Meeting Abstract

Macgrogan, D.; Alvarez, S.; Kalakonda, N.; Deblasio, T.; Boccuni, P.; Nimer, S. D.
Blood (2002)

Fulltext@MSK | Save

PKC412, an oral FLT3 inhibitor, has activity in mutant FLT3 acute myeloid leukemia (AML): A phase II clinical trial

Meeting Abstract

Stone, R. M.; Klimek, V.; DeAngelo, D. J.; Nimer, S.; Estey, E.; Galinsky, I.; Neuberg, D.; Yap, A.; Fox, E. A.; Gilliland, D. G.; more...
Blood (2002)

Fulltext@MSK | Save

TEL/AML1, the leukemia-related chimeric protein, overcomes drug resistance through transcriptional repression of multidrug resistance-1 (MDR-1) gene expression